Dr Brittney Lynn Morgan, DO | |
7910 Allen Rd Ste 101, Allen Park, MI 48101-1704 | |
(313) 436-4746 | |
(313) 436-4552 |
Full Name | Dr Brittney Lynn Morgan |
---|---|
Gender | Female |
Speciality | General Surgery |
Experience | 10 Years |
Location | 7910 Allen Rd Ste 101, Allen Park, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831516277 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0127X | Surgery - Trauma Surgery | 5101025077 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Beaumont Hospital - Taylor | Taylor, MI | Hospital |
Beaumont Hospital - Dearborn | Dearborn, MI | Hospital |
Beaumont Hospital - Wayne | Wayne, MI | Hospital |
Henry Ford Wyandotte Hospital | Wyandotte, MI | Hospital |
Beaumont Hospital - Trenton | Trenton, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Michigan Surgical Associates Pllc | 5799926275 | 2 |
News Archive
ESMO announced the publication of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS), a tool to assist oncology clinicians in evaluating the most effective anti-cancer medicines for their patients.
Certain brain processes happen in the blink of an eye – and even faster – which has made pinpointing these events virtually impossible. The advent of magnetoencephalography (MEG) changed all that, enabling researchers to capture brain electrical activity measured in milliseconds, and offering the potential to reveal the nature of innumerable brain disorders and diseases.
A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress.
MabVax Therapeutics Holdings, Inc., a clinical-stage oncology drug-development company, announces receipt of notice from the U.S. Food and Drug Administration authorizing initiation of a Phase I clinical trial with 89Zr-HuMab-5B1 as a new generation PET scan cancer imaging agent in patients with pancreatic cancer.
With this morning's passing of Massachusetts Senator Ted Kennedy from a brain tumor, Wilmington's Christopher Grundner says he feels that it could lead to quicker diagnoses for others affected by the disease and more support for the cause.
› Verified 1 days ago
Entity Name | Michigan Surgical Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861832578 PECOS PAC ID: 5799926275 Enrollment ID: O20130725000505 |
News Archive
ESMO announced the publication of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS), a tool to assist oncology clinicians in evaluating the most effective anti-cancer medicines for their patients.
Certain brain processes happen in the blink of an eye – and even faster – which has made pinpointing these events virtually impossible. The advent of magnetoencephalography (MEG) changed all that, enabling researchers to capture brain electrical activity measured in milliseconds, and offering the potential to reveal the nature of innumerable brain disorders and diseases.
A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress.
MabVax Therapeutics Holdings, Inc., a clinical-stage oncology drug-development company, announces receipt of notice from the U.S. Food and Drug Administration authorizing initiation of a Phase I clinical trial with 89Zr-HuMab-5B1 as a new generation PET scan cancer imaging agent in patients with pancreatic cancer.
With this morning's passing of Massachusetts Senator Ted Kennedy from a brain tumor, Wilmington's Christopher Grundner says he feels that it could lead to quicker diagnoses for others affected by the disease and more support for the cause.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Brittney Lynn Morgan, DO 7910 Allen Rd, Allen Park, MI 48101-1704 Ph: (313) 436-4746 | Dr Brittney Lynn Morgan, DO 7910 Allen Rd Ste 101, Allen Park, MI 48101-1704 Ph: (313) 436-4746 |
News Archive
ESMO announced the publication of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS), a tool to assist oncology clinicians in evaluating the most effective anti-cancer medicines for their patients.
Certain brain processes happen in the blink of an eye – and even faster – which has made pinpointing these events virtually impossible. The advent of magnetoencephalography (MEG) changed all that, enabling researchers to capture brain electrical activity measured in milliseconds, and offering the potential to reveal the nature of innumerable brain disorders and diseases.
A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress.
MabVax Therapeutics Holdings, Inc., a clinical-stage oncology drug-development company, announces receipt of notice from the U.S. Food and Drug Administration authorizing initiation of a Phase I clinical trial with 89Zr-HuMab-5B1 as a new generation PET scan cancer imaging agent in patients with pancreatic cancer.
With this morning's passing of Massachusetts Senator Ted Kennedy from a brain tumor, Wilmington's Christopher Grundner says he feels that it could lead to quicker diagnoses for others affected by the disease and more support for the cause.
› Verified 1 days ago
M. Redwan Kubaisi, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 8449 Park Ave, Allen Park, MI 48101 Phone: 313-383-7830 Fax: 313-383-7831 |